Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action

Hypertension

Volumn 27, Issue 3 I, 1996, Pages 414-420

  Staessen, Jan A ^a   Thijs, Lutgarde ^b   Bieniaszewski, Leszek ^b   O'Brien, Eoin T ^b   Palatini, Paolo ^b   Davidson, Christopher ^b   Dobovisek, Jurij ^b   Jääskivi, Matti ^b   Laks, Tovio ^b   Lehtonen, Aapo ^b   Vanhanen, Hannu ^b   Webster, John ^b   Fagard, Robert ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

antihypertensive therapy; blood pressure monitoring; blood pressure monitoring, ambulatory; clinical trials; placebo

Indexed keywords

ENALAPRIL; HYDROCHLOROTHIAZIDE; NITRENDIPINE; PLACEBO;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPHYGMOMANOMETRY;

EID: 9044243017     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.3.414     Document Type: Article

References (51)

1. Amery A, Birkenhäger W, Bulpitt CJ, Clement D, De Leeuw P, Dollery CT, Fagard R, Fletcher A, Forette F, Leonetti G, O'Brien ET, O'Malley K, Rodicio JL, Rosenfeld J, Staessen J, Strasser T, Terzoli L, Thijs L, Tuomilehto J, Webster J. Syst-Eur: a multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol and organisation. Aging. 1991;3:287-302.
2. The Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. Hypertension. 1993;22:392-403.
3. Staessen J, Amery A, Clement D, Cox J, De Cort P, Fagard R, Guo C, Marin R, O'Brien ET, O'Malley K, Mancia G, Parati G, Ravogli A, Thijs L, Webster J. Twenty-four hour blood pressure monitoring in the Syst-Eur trial. Aging. 1992;4:85-91.
4. Staessen JA, Thijs L, Clement D, Davidson C, Fagard R, Lehtonen A, Mancia G, Palatini P, O'Brien ET, Parati G, Webster J, Amery A, on behalf of the Syst-Eur Investigators. The ambulatory blood pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. J Hypertens. 1994;12:1035-1039.
5. White WB, Berson AS, Robbins C, Jamieson MJ, Prisant ML, Roccella E, Sheps SG. National standard for measurement of resting and ambulatory blood pressures with automated sphygmo-manometers. Hypertension. 1993;21:504-509.
6. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, O'Malley K, Jamieson M, Altman D, Bland M, Atkins N. The British Hypertension Society protocol for the evaluation of automated and semiautomated blood pressure measuring devices with special reference to ambulatory systems. J Ambul Monit. 1991;4:207-228.
7. Katz S, Down TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1971;10:20-30.
8. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: the index of ADL: a standard measure of biological and psychosocial function. JAMA. 1963;185:914-919.
9. Yamada Y, Ishizaki M, Kido T, Honda R, Tsuritani I, Ikai E, Yamaya H. Alcohol, high blood pressure, and serum γ-glutamyl-transpeptidase level. Hypertension. 1991;18:819-826.
10. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Mancia G, O'Brien ET, Vyncke G, Amery A. Reference values for the ambulatory blood pressure and the blood pressure measured at home: a population study. J Hum Hypertens. 1991;5:355-361.
11. Casadei R, Parati G, Pomidossi G, Groppelli A, Trazzi S, Di Rienzo M, Mancia G. 24-Hour blood pressure monitoring: evaluation of Space Labs 5300 monitor by comparison with intra-arterial blood pressure recording in ambulant subjects. J Hypertens. 1988;6:797-803.
12. Thijs L, Staessen J, Fagard R. Analysis of the diurnal blood pressure curve. High Blood Pressure Cardiovasc Prev. 1992;1:17-28.
13. Thijs L, Amery A, Clement D, Cox J, De Cort P, Fagard R, Fowler G, Guo C, Mancia G, Marin R, O'Brien E, O'Malley K, Palatini P, Parati G, Petrie J, Ravogli A, Rosenfeld J, Staessen J, Webster J. Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension. J Hypertens. 1992;10:693-699.
14. Cole JWL, Grizzle JE. Applications of multivariate analysis of variance to repeated measures experiments. Biometrics. 1966;22:810-828.
15. Whelton A, Eff J, Magner DJ. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring. J Clin Pharmacol. 1992;32:808-815.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
17. Staessen J, Bert P, Bulpitt C, De Cort P, Fagard R, Fletcher A, Kivinen P, Lehtomaki E, Leonetti G, O'Brien E, Rodicio J, Rosenfeld J, Slovic D, Thijs L, Tozzi N, Tuomilehto J, Yodfat Y, Vanhanen H, Vanska O, Webster J. Nitrendipine in older patients with isolated systolic hypertension: second progress report on the Syst-Eur Trial. J Hum Hypertens. 1993;7:265-271.
18. Girerd X, Amery A, Birkenhäger W, Bulpitt CJ, Cox J, De Leeuw P, De Cort P, Fagard R, Fletcher A, Forette F, Fowler G, Leonetti G, O'Brien ET, O'Malley K, Petrie J, Rodicio JL, Rosenfeld J, Slovick D, Staessen J, Terzoli L, Thijs L, Tuomilehto J, Webster J, Yodfat Y. Syst-Eur un essai multicentrique du traitement de l'hypertension systolique du sujet âgé. Premier rapport intermédiaire. Arch Mal Coeur. 1992;85:1243-1247.
19. SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
20. The Scientific Committee. Consensus document on non-invasive ambulatory blood pressure monitoring. J Hypenens. 1990;8(suppl 6):S135-S140.
21. Pickering TG, O'Brien ET. Second international consensus meeting on twenty-four-hour blood pressure measurement: consensus and conclusions. J Hypertens. 1991;9(suppl 8):S2-S6.
22. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coal hypertension? JAMA. 1988;259:225-228.
23. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet. 1983;2:695-698.
24. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
25. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, Part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
26. Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens. 1989;7(suppl 3):S29-S32.
27. Conway J, Johnston J, Coats A, Somers V, Sleight P. The use of ambulatory blood pressure monitoring to improve the accuracy and to reduce the number of subjects in clinical trials of antihypertensive agents. J Hypertens. 1988;6:111-116.
28. Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens. 1992:10:385-391.
29. Coats AJS, Conway J, Somers VK, Isea JE, Sleight P. Ambulatory pressure monitoring in the assessment of antihypertensive therapy. Cardiovasc Drugs Ther. 1989;3:303-311.
30. Pickering TG. Ambulatory Monitoring and Blood Pressure Variability. London, UK: Science Press Ltd; 1991.
31. Parati G, Pomidossi G, Casadei B, Mancia G. Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension. 1985;7:597-601.
32. Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G. Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens. 1991;9:115-119.
33. Could BA, Mann S, Davies AB, Altman DG, Raftery EB. Does placebo lower blood pressure? Lancet. 1981;2:1377-1381.
34. Mutti E, Trazzi S, Omboni S, Parati G, Mancia G. Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens. 1991;9:361-364.
35. Dupont AG, Van der Niepen P, Six RO. Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol. 1987;24:106-109.
36. Staessen J, Fagard R, Lijnen P, Thijs L, Van Hoof R, Amery A. Ambulatory blood pressure monitoring in clinical trials. J Hypertens. 1991;9(suppl 1):S13-S19.
37. Palatini P, Pessina AC, Dal Palù C. The Hypertension and Ambulatory Recording Venetia Study (HARVEST): a trial on the predictive value of ambulatory monitoring for the development of fixed hypertension in patients with borderline hypertension. High Blood Pressure Cardiovasc Prev. 1992;3:11-18.
38. Staessen J, Bulpitt CJ, O'Brien E, Cox J, Fagard R, Stanton A, Thijs L, Van Hulle S, Vyncke G, Amery A. The diurnal blood pressure profile: a population study. Am J Hypertens. 1992;5:386-392.
39. Palatini P, Penzo M, Guzzardi G, Anaclerio M, Pessina AC. Ambulatory blood pressure monitoring in the assessment of antihypertensive treatment: 24-h blood pressure control with lacidipine once a day. J Hypertens. 1991;9(suppl 3):S61-S66.
40. Paran E, Landau-Salzberg M, Kobrin Y, Viskoper R. Effect of placebo on office and 24 hour noninvasive ambulatory blood pressure measurements. J Hum Hypertens. 1993;7:567-570.
41. Weber MA, Drayer JIM, Wyle FA, De Young JL. Reproducibility of the whole-day blood pressure pattern in essential hypertension. Clin Exp Hypertens A. 1982;4:1377-1390.
42. Drayer JIM, Weber MA, De Young JL, Brewer DD. Long-term BP monitoring in the evaluation of antihypertensive therapy. Arch Intern Med. 1983;143:898-901.
43. Bellet M, Pagny JY, Chatellier G, Corvol P, Ménard J. Evaluation of slow release nicardipine in essential hypertension by casual and ambulatory blood pressure measurements: effects of acute versus chronic administration. J Hypertens. 1987;5:599-604.
44. Poggi L, Vaisse B, Bernard F, Agabriel P. Etude de l'effet placebo par mesure ambulatoire non sanglante de la pression artérielle. Arch Mal Coeur. 1987;80:1031-1036.
45. Parati G, Pomidossi G, Casadei R, Trazzi S, Ravogli A, Zanchetti A, Mancia G. Evaluation of the antihypertensive effect of celiprolol by ambulatory blood pressure monitoring. Am J Cardiol. 1988;61:27C-33C.
46. Staessen JA, O'Brien ET, Amery AK, Atkins N, Baumgart P, De Cort P, Degaute JP, Dolenc P, De Gaudemaris R, Enström I, Fagard R, Gosse P, Gourlay S. Hayashi H, Imai Y, James G, Kawasaki T, Kuschnir E, Kuwajima I, Lindholm L, Liu L, Macor F, Mancia G, McGrath B, Middeke M, Ming J, Omboni S, Otsuka K, Palatini P, Parati G, Pieper C, Verdecchia P, Zachariah P, Zhang W. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens. 1994; 12(suppl 7):S1-S12.
47. Fagard R, Bielen E, Staessen J, Thijs L, Amery A. Response of ambulatory blood pressure to antihypertensive therapy guided by clinic pressure. Am J Hypertens. 1993;6:648-653.
48. Mansoor GA, White WB. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk. 1994;1:136-142.
49. Sassano P, Chatellier G, Corvol P, Menard J. Influence of observer's expectation on the placebo effect in blood pressure trials. Curr Ther Res. 1987;41:305-312.
50. Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension. 1993;21:510-524.
51. Staessen JA, Thijs L, Mancia G, Parati G, O'Brien ET, on behalf of the Syst-Eur Investigators. Clinical trials with ambulatory blood pressure monitoring: fewer patients needed? Lancet. 1994;344: 1552-1556.